Research Article

The Correlation between Endotoxin, D-Lactate, and Diamine Oxidase with Endoscopic Activity in Inflammatory Bowel Disease

Table 1

Baseline characteristics of patients with CD and UC.

Total ()CD ()UC ()

Median age (years, IQR)31.5 (24.0-47.3)28.0 (21.0-33.0)46.0 (29.0-49.0)
Median disease duration (years, IQR)3.0 (1.0-4.0)3.0(1.0-4.0)3.0 (0.5-4.0)
Gender (%)
 Male100 (67.11)56 (68.29)44 (65.67)
 Female49 (32.89)26 (31.71)23 (34.33)
Smoking history (%)
 Yes10 (6.71)3 (3.66)7 (10.45)
 No139 (93.29)79 (96.34)60 (89.55)
CD location (%)
 Ileal (L1)19 (12.67)19 (22.90)
 Colonic (L2)18 (12.00)18 (21.69)
 Ileocolonic (L3)44 (29.53)44 (53.65)
 Upper gastrointestinal involvement (L4)1(0.67)1(1.22)
UC extent (Montreal) (%)
 Proctitis (E1)9 (6.00)9 (13.43)
 Left-sided (E2)15 (10.00)15 (22.39)
 Extensive (E3)43 (28.67)43 (64.18)
Medication
 None12 (8.00)9 (10.84)3 (4.48)
 5-ASA96 (64.43)34 (41.46)62 (92.54)
 Steroids32 (21.33)14 (16.87)18 (26.87)
 Thiopurine15 (10)13 (15.67)2 (2.99)
 Anti-TNF46 (30.67)43 (51.80)3 (4.48)